A small number of participants who were diagnosed with AD-dementia or MCI did not have both tau and amyloid pathology (e.g. negative Aβ-PET, normal CSF Aβ42 and abnormal CSF tau levels), and thus neuropathological AD was likely not the cause of their cognitive impairment. Here, MAPT is linked to Cognitive impairment.